LEUCOVORIN

This brand name is authorized in Australia, Estonia, Hong Kong, Israel, Japan, New Zealand, Turkey

Active ingredients

The drug LEUCOVORIN contains one active pharmaceutical ingredient (API):

1 Calcium folinate UNII 935E97BOY8 - FOLIC ACID

Calcium folinate is an active metabolite of folinic acid and essential coenzyme for nucleic acid synthesis in cytotoxic therapy. Calcium folinate is frequently used to diminish the toxicity and counteract the action of folate antagonists, such as methotrexate. Read about Calcium folinate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AF03	Calcium folinate	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1610R, 1704Q, 1899Y, 1904F, 2308L, 5904R
Country: EE	Ravimiamet	Identifier(s): 1612202, 1780107
Country: HK	Department of Health Drug Office	Identifier(s): 35172
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1387, 8845, 8856
Country: JP	医薬品医療機器総合機構	Identifier(s): 3929004F2030
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3632, 3633, 3634, 8641
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699638770250, 8699638770267, 8699638770274, 8699638770281